{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:30:32Z","timestamp":1787009432586,"version":"build-2736575974"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA036289"],"award-info":[{"award-number":["R01DA036289"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54AG062319"],"award-info":[{"award-number":["U54AG062319"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012876","name":"Center for Women\u2019s Health Research, University of Colorado","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012876","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014605","name":"Sage Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Although exogenous progesterone may hold promise as a treatment for nicotine use disorders, it is unclear whether it is similarly effective in males and females. This study examined the effects of progesterone on nicotine use disorder comprehensively using behavioral, psychological, and neural measures in male and female smokers exposed to brief abstinence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Methods<\/jats:title>\n                    <jats:p>Thirty-three male and 33 female non-treatment-seeking smokers participated in a double-blind, randomized, placebo-controlled crossover study of 200 mg of progesterone or placebo daily over a four-day abstinence period. Smoking behavior and subjective effects of nicotine were assessed at baseline and after final drug administration. Nicotine withdrawal, smoking urges, mood states, and neural response to smoking cues were measured at baseline, after the first drug administration, and after the final drug administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>No main effect of drug (progesterone vs. placebo) emerged for any outcome. Significant sex by drug interactions emerged for nicotine withdrawal (p = .020), perceived strength of nicotine (p = .040), and perceived bad effects of nicotine (p = .029). Males receiving progesterone reported worse nicotine withdrawal (p = .046) and a trend towards decreased bad effects of nicotine (p = .070). Males on progesterone also reported greater tension and anxiety relative to placebo (p = .021). Females on progesterone perceived nicotine\u2019s effects as being stronger relative to placebo (p = .046).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Progesterone causes sex-dependent effects on smoking-related outcomes during brief abstinence. Specifically, progesterone in males may increase rather than decrease nicotine withdrawal and negative affect during abstinence, potentially hindering efforts to quit smoking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications<\/jats:title>\n                    <jats:p>In male and female smokers undergoing a brief period of abstinence, we examined the effects of progesterone on smoking outcomes. While progesterone had limited effects in female smokers, in males, it worsened nicotine withdrawal and negative affect. Our findings emphasize the importance of analyzing sex differences in future studies examining progesterone as a potential treatment and suggest that progesterone in males could potentially exacerbate aspects of nicotine dependence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinicaltrials.gov registration<\/jats:title>\n                    <jats:p>NCT01954966. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01954966<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ntr\/ntac146","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:51:11Z","timestamp":1655466671000},"page":"1898-1905","source":"Crossref","is-referenced-by-count":13,"title":["Progesterone Increases Nicotine Withdrawal and Anxiety in Male but Not Female Smokers During Brief Abstinence"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0995-5060","authenticated-orcid":false,"given":"Andrew M","family":"Novick","sequence":"first","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of Colorado-Anschutz Medical Campus , Aurora, CO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korrina A","family":"Duffy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of Colorado-Anschutz Medical Campus , Aurora, CO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Anschutz Medical Campus , Aurora, CO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1248-4199","authenticated-orcid":false,"given":"Mary D","family":"Sammel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of Colorado-Anschutz Medical Campus , Aurora, CO , USA"},{"name":"Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado-Anschutz Medical Campus , Aurora, CO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A","family":"Strasser","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Sofuoglu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Yale School of Medicine, Yale University , New Haven, CT , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kuzma","sequence":"additional","affiliation":[{"name":"Larner College of Medicine, University of Vermont , Burlington, VM , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Loughead","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Neill","family":"Epperson","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, School of Medicine, University of Colorado-Anschutz Medical Campus , Aurora, CO , USA"},{"name":"Department of Family Medicine, School of Medicine, University of Colorado-Anschutz Medical Campus , Aurora, CO , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"3","key":"2022111214041211700_CIT0001","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/tc.11.3.228","article-title":"Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study","volume":"11","author":"DiFranza","year":"2002","journal-title":"Tob Control"},{"issue":"5","key":"2022111214041211700_CIT0002","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/10826080701202486","article-title":"Progression to daily smoking: is there a gender difference among cessation treatment seekers?","volume":"42","author":"Thorner","year":"2007","journal-title":"Subst Use Misuse"},{"key":"2022111214041211700_CIT0003","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ypmed.2016.07.013","article-title":"Sex\/gender differences in smoking cessation: a review","volume":"92","author":"Smith","year":"2016","journal-title":"Prev Med"},{"issue":"1","key":"2022111214041211700_CIT0004","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41386-018-0125-6","article-title":"Sex differences in neural mechanisms mediating reward and addiction","volume":"44","author":"Becker","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"2022111214041211700_CIT0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.bbr.2016.04.004","article-title":"Estradiol promotes the rewarding effects of nicotine in female rats","volume":"307","author":"Flores","year":"2016","journal-title":"Behav Brain Res"},{"issue":"11","key":"2022111214041211700_CIT0006","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11920-014-0511-7","article-title":"Ovarian hormones and drug abuse","volume":"16","author":"Maria","year":"2014","journal-title":"Curr Psychiatry Rep"},{"issue":"12","key":"2022111214041211700_CIT0007","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11920-020-01197-6","article-title":"Administration of exogenous hormones and the implications for cigarette smoking-related behaviors","volume":"22","author":"Allen","year":"2020","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"2022111214041211700_CIT0008","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1037\/a0021265","article-title":"Role of progesterone in nicotine addiction: evidence from initiation to relapse","volume":"18","author":"Lynch","year":"2010","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"2022111214041211700_CIT0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s002130051033","article-title":"Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women","volume":"145","author":"Justice","year":"1999","journal-title":"Psychopharmacology"},{"issue":"3","key":"2022111214041211700_CIT0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1037\/1064-1297.7.3.274","article-title":"Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans","volume":"7","author":"Sofuoglu","year":"1999","journal-title":"Exp Clin Psychopharmacol"},{"issue":"6","key":"2022111214041211700_CIT0011","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/ntr\/ntx118","article-title":"Postpartum changes in mood and smoking-related symptomatology: an ecological momentary assessment investigation","volume":"20","author":"Allen","year":"2018","journal-title":"Nicotine Tob Res"},{"key":"2022111214041211700_CIT0012","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.psyneuen.2017.09.012","article-title":"Progesterone for smoking relapse prevention following delivery: a pilot, randomized, double-blind study","volume":"86","author":"Forray","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"1-2","key":"2022111214041211700_CIT0013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0091-3057(01)00527-5","article-title":"Progesterone treatment during the early follicular phase of the menstrual cycle: effects on smoking behavior in women","volume":"69","author":"Sofuoglu","year":"2001","journal-title":"Pharmacol Biochem Behav"},{"key":"2022111214041211700_CIT0014","doi-asserted-by":"crossref","first-page":"106570","DOI":"10.1016\/j.addbeh.2020.106570","article-title":"Effect of exogenous progesterone administration on smoking topography","volume":"112","author":"Allen","year":"2021","journal-title":"Addict Behav"},{"key":"2022111214041211700_CIT0015","doi-asserted-by":"crossref","first-page":"106148","DOI":"10.1016\/j.addbeh.2019.106148","article-title":"Effect of exogenous progesterone administration on cigarette smoking-related symptomology in oral contraceptive users who smoke","volume":"102","author":"Harrison","year":"2020","journal-title":"Addict Behav"},{"issue":"1","key":"2022111214041211700_CIT0016","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psyneuen.2010.07.005","article-title":"Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers","volume":"36","author":"Sofuoglu","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"2022111214041211700_CIT0017","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/hup.1055","article-title":"Progesterone effects on subjective and physiological responses to intravenous nicotine in male and female smokers","volume":"24","author":"Sofuoglu","year":"2009","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"10","key":"2022111214041211700_CIT0018","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/add.14645","article-title":"Exogenous progesterone for smoking cessation in men and women: a pilot double-blind, placebo-controlled randomized clinical trial","volume":"114","author":"Tosun","year":"2019","journal-title":"Addiction"},{"issue":"6","key":"2022111214041211700_CIT0019","first-page":"449","article-title":"Opposite effects of inhibitory and excitatory neurosteroids on [3H]dopamine release from rat nucleus accumbens","volume":"50","author":"Jaworska-Feil","year":"1998","journal-title":"Pol J Pharmacol"},{"issue":"6","key":"2022111214041211700_CIT0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1179\/016164107X166281","article-title":"Allopregnanolone modulates striatal dopamingergic activity of rats under different gonadal hormones conditions","volume":"29","author":"Laconi","year":"2007","journal-title":"Neurological Research"},{"issue":"2","key":"2022111214041211700_CIT0021","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neubiorev.2010.04.003","article-title":"The role of progestins in the behavioral effects of cocaine and other drugs of abuse: human and animal research","volume":"35","author":"Anker","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"2022111214041211700_CIT0022","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"2022111214041211700_CIT0023","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neulet.2013.02.023","article-title":"Neurosteroid allopregnanolone attenuates development of nicotine withdrawal behavior in mice","volume":"541","author":"Thakre","year":"2013","journal-title":"Neurosci Lett"},{"issue":"2","key":"2022111214041211700_CIT0024","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/mol.58.2.341","article-title":"Steroid inhibition of rat neuronal nicotinic \u03b14\u03b22 receptors expressed in HEK 293 cells","volume":"58","author":"Paradiso","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"6","key":"2022111214041211700_CIT0025","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1046\/j.1471-4159.1997.68062412.x","article-title":"Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes","volume":"68","author":"Bullock","year":"2002","journal-title":"J Neurochem"},{"key":"2022111214041211700_CIT0026","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2019.01.039","article-title":"Menstrual cycle phase modulates responses to smoking cues in the putamen: preliminary evidence for a novel target","volume":"198","author":"Franklin","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2022111214041211700_CIT0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13293-016-0078-6","article-title":"Influence of menstrual cycle phase on resting-state functional connectivity in naturally cycling, cigarette-dependent women","volume":"7","author":"Wetherill","year":"2016","journal-title":"Biol Sex Differ"},{"key":"2022111214041211700_CIT0028","doi-asserted-by":"crossref","first-page":"723632","DOI":"10.1155\/2014\/723632","article-title":"Sex differences and menstrual cycle phase-dependent modulation of craving for cigarette: an FMRI pilot study","volume":"2014","author":"Mendrek","year":"2014","journal-title":"Psychiatry J"},{"key":"2022111214041211700_CIT0029","author":"PROMETRIUM- Progesterone Capsule [Package Insert].","year":"2021"},{"issue":"3","key":"2022111214041211700_CIT0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2174\/1874473710801030340","article-title":"Contingency management for smoking cessation: where do we go from here?","volume":"1","author":"Ledgerwood","year":"2008","journal-title":"CDAR"},{"issue":"2","key":"2022111214041211700_CIT0031","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/14622200210123581","article-title":"Biochemical verification of tobacco use and cessation","volume":"4","author":"SRNT Subcommittee on Biochemical Verification.","year":"2002","journal-title":"Nicotine & Tobacco Research"},{"issue":"1","key":"2022111214041211700_CIT0032","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/1471-2458-9-433","article-title":"Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler","volume":"9","author":"Kralikova","year":"2009","journal-title":"BMC Public Health"},{"issue":"3","key":"2022111214041211700_CIT0033","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0306-4603(85)90014-0","article-title":"Smoking topography and carbon monoxide levels in smokers","volume":"10","author":"Burling","year":"1985","journal-title":"Addict Behav"},{"key":"2022111214041211700_CIT0034","first-page":"788","article-title":"Validation and replication of the Nicotine Effects Questionnaire.","volume-title":"Nicotine & Tobacco Research","author":"Niaura","year":"2003"},{"issue":"2","key":"2022111214041211700_CIT0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1037\/0893-164X.21.2.216","article-title":"Confirmatory factor analysis of the Minnesota nicotine withdrawal scale","volume":"21","author":"Toll","year":"2007","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"2022111214041211700_CIT0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14622200020032051","article-title":"Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings","volume":"3","author":"Cox","year":"2001","journal-title":"Nicotine Tobacco Res"},{"issue":"11","key":"2022111214041211700_CIT0037","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1360-0443.1991.tb01732.x","article-title":"The development and initial validation of a questionnaire on smoking urges","volume":"86","author":"Tiffany","year":"1991","journal-title":"Br J Addict"},{"key":"2022111214041211700_CIT0038","volume-title":"Profile of Mood States","author":"McNair","year":"1971"},{"key":"2022111214041211700_CIT0039","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.drugalcdep.2017.05.044","article-title":"Multi-site exploration of sex differences in brain reactivity to smoking cues: consensus across sites and methodologies","volume":"178","author":"Dumais","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"2022111214041211700_CIT0040","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/npp.2015.9","article-title":"Insula\u2013dorsal anterior cingulate cortex coupling is associated with enhanced brain reactivity to smoking cues","volume":"40","author":"Janes","year":"2015","journal-title":"Neuropsychopharmacol"},{"issue":"4","key":"2022111214041211700_CIT0041","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.neuroimage.2003.12.023","article-title":"Multilevel linear modelling for FMRI group analysis using Bayesian inference","volume":"21","author":"Woolrich","year":"2004","journal-title":"NeuroImage"},{"key":"2022111214041211700_CIT0042","article-title":"Neural cue reactivity during acute abstinence predicts short-term smoking relapse","author":"Allenby","year":"2019","journal-title":"Addict Biol"},{"issue":"1","key":"2022111214041211700_CIT0043","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroimage.2011.12.024","article-title":"Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies","volume":"60","author":"Engelmann","year":"2012","journal-title":"Neuroimage"},{"key":"2022111214041211700_CIT0044","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team.","year":"2020"},{"issue":"3","key":"2022111214041211700_CIT0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tobacco Res"},{"issue":"2","key":"2022111214041211700_CIT0046","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.drugalcdep.2009.11.002","article-title":"Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats","volume":"107","author":"Anker","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2022111214041211700_CIT0047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-008-1371-9","article-title":"Effects of allopregnanolone on the reinstatement of cocaine-seeking behavior in male and female rats","volume":"203","author":"Anker","year":"2009","journal-title":"Psychopharmacology"},{"issue":"3","key":"2022111214041211700_CIT0048","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.npp.1300887","article-title":"Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men","volume":"31","author":"Evans","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"2022111214041211700_CIT0049","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1037\/1064-1297.15.5.453","article-title":"Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study","volume":"15","author":"Sofuoglu","year":"2007","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"2022111214041211700_CIT0050","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/epi.14693","article-title":"Extrasynaptic GABA-A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures","volume":"60","author":"Reddy","year":"2019","journal-title":"Epilepsia"},{"issue":"1-2","key":"2022111214041211700_CIT0051","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/jnr.23853","article-title":"Sex differences in the anticonvulsant activity of neurosteroids","volume":"95","author":"Samba Reddy","year":"2017","journal-title":"J Neurosci Res"},{"issue":"8","key":"2022111214041211700_CIT0052","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.psyneuen.2009.02.003","article-title":"Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators","volume":"34","author":"Andr\u00e9en","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"2022111214041211700_CIT0053","first-page":"139","article-title":"Alcohol, GABAA-benzodiazepine receptor complex, and aggression.","volume-title":"Recent Developments in Alcoholism: Volume 13: Alcohol and Violence - Epidemiology Neurobiology Psychology Family Issues. Recent Development in Alcoholism","author":"Miczek","year":"1997"}],"container-title":["Nicotine &amp; Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntac146\/44799228\/ntac146.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/24\/12\/1898\/47012078\/ntac146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/24\/12\/1898\/47012078\/ntac146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,12]],"date-time":"2022-11-12T09:05:36Z","timestamp":1668243936000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/24\/12\/1898\/6609914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":53,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6,17]]},"published-print":{"date-parts":[[2022,11,12]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntac146","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,6,17]]}}}